Retatrutide: The Triple-Agonist Mechanism Retatrutide (LY3437943) is an oxyntomodulin-based peptide that has been engineered to possess potent activity at three distinct receptors
in tablet-forming or capsule-filling operations
Applications: In Pharmaceutical: S Acetyl L Glutathione Powder has a palliative effect on other symptoms due to liver disease and protects against leukopenia due to radiation therapy, radiopharmaceuticals, oncology drugs, and inflammation of bone marrow tissues due to radiation therapy or drugs
To view or add a comment, sign in Genentech Reports the US FDA's Approval of Gazyva (Obinutuzumab) to Treat Lupus Nephritis #genentech #gazyva #obinutuzumab #lupusnephritis #usfda #regulatory #monoclonalantibody #nobility #regency #pii #piii #ro5072759 #rg7159 #r7159 #ga101 To view or add a comment, sign in Potential future royalty income from Metsera/Pfizer* obesity drug candidates As highlighted in our 2025 half-yearly results, IP Group has financial exposure to several of Metseras obesity drug programmes, following its acquisition of our former portfolio company Zihipp Limited in 2023
Carnitine 100000 Nutrend,
You may be a good candidate if: You have type 2 diabetes that isnt well-controlled with first-line treatments like metformin You need to improve your HbA1c levels (a measure of blood sugar control) You want a diabetes medication that may help with weight management Youre looking to reduce your risk of cardiovascular complications of diabetes Mounjaro has shown significant effectiveness in lowering HbA1c levels, with clinical trials showing reductions of up to 2.4 percentage points at higher doses
